Ibuprofen disrupts a WNK1/GSK3β/SRPK1 protein complex required for expression of tumor-related splicing variant RAC1B in colorectal cells
A major risk factor promoting tumor development is chronic inflammation and the use of nonsteroidal anti-inflammatory drugs (NSAID), including ibuprofen, can decrease the risk of developing various types of cancer, including colorectal cancer (CRC). Although the molecular mechanism behind the antitu...
Autor principal: | |
---|---|
Outros Autores: | , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2021
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.18/7498 |
País: | Portugal |
Oai: | oai:repositorio.insa.pt:10400.18/7498 |